Exagen Diagnostics Awarded $400,000 in Grants Under the QTDP Program
Exagen Diagnostics Inc has been awarded $400,000 in funding under the IRS Qualifying Therapeutic Discovery Project (QTDP) program.
Read MoreSearch Results for: liver disease
Clarient Launches Mammostrat Test
Clarient Inc launches Mammostrat, a test designed to help quantify the likelihood of recurrence of breast cancer following surgery and initial treatment.
Read MoreWarnex, Epigenomics Launch Septin9 Test in Canada
Warnex’s Septin9 test is based on Epigenomics’ patented biomarker Septin9 and DNA methylation technologies.
Read More
Product Showcase
Multiplex Lyme, Syphilis, and ToRCH IgG The AtheNA Multi-Lyte® menu offered by Alere Inc, Waltham, Mass, includes three new infectious disease assays. Borrelia VlsE-1/ pepC10 is used as a first-tier test to detect qualitative levels of B. bu
Read MoreAriana Pharma Partners to Improve Diagnosis of Chronic Hepatitis
Ariana Pharma has entered into a partnership to improve the diagnosis and prognosis of chronic hepatitis.
Read More